Harefuah. Foreign edPub Date : 2020-01-01DOI: 10.1016/B978-0-323-67509-3.00007-X
E. Dann, S. Gillis, E. Cohen, Y. Ilan
{"title":"[Transfusion-related acute lung injury].","authors":"E. Dann, S. Gillis, E. Cohen, Y. Ilan","doi":"10.1016/B978-0-323-67509-3.00007-X","DOIUrl":"https://doi.org/10.1016/B978-0-323-67509-3.00007-X","url":null,"abstract":"","PeriodicalId":88502,"journal":{"name":"Harefuah. Foreign ed","volume":"144 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76505784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yaron Zafrir, Sharon Baum, Shoshi Greenberger, Anna Lyakhovitsky, Aviv Barzilai
{"title":"[ALOPECIA AREATA].","authors":"Yaron Zafrir, Sharon Baum, Shoshi Greenberger, Anna Lyakhovitsky, Aviv Barzilai","doi":"10.15557/pimr.2019.0060","DOIUrl":"https://doi.org/10.15557/pimr.2019.0060","url":null,"abstract":"INTRODUCTION\u0000Alopecia areata (AA) is an organ specific autoimmune disease. Similar to other autoimmune diseases, its pathogenesis is believed to be an interaction of genetic, environmental and immune factors. Studies have shown that autoreactive lymphocytes affect anagen hair follicles leading to subsequent shedding of hairs and alopecia. Clinically, the disease is characterized by sudden nonscarring hair loss that usually involves the scalp, but may also affect the face and other body areas, and indeed the entire body hair. AA may appear for the first time at any age, affecting both children and adults, but it occurs primarily at a young age with a peak incidence in the second and third decade of life. The disease causes pronounced social and psychological impact. The main therapeutic approaches include immunosuppression through anti-inflammatory agents and immunomodulation based on skin sensitization.","PeriodicalId":88502,"journal":{"name":"Harefuah. Foreign ed","volume":"61 1","pages":"622-625"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83227601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Harefuah. Foreign edPub Date : 2019-05-11DOI: 10.26226/morressier.5c76c8bce2ea5a723761266f
Kzia Cohen, Ehud Paz
{"title":"[END-OF-LIFE PROGNOSTICATION IN ACUTE HOSPITAL PALLIATIVE PATIENTS: IS THE PALLIATIVE PERFORMANCE SCALE USEFUL?]","authors":"Kzia Cohen, Ehud Paz","doi":"10.26226/morressier.5c76c8bce2ea5a723761266f","DOIUrl":"https://doi.org/10.26226/morressier.5c76c8bce2ea5a723761266f","url":null,"abstract":"AIMS\u0000This study examined PPS (Palliative Performance Scale) use as a tool estimating life expectancy in patients with various life-threatening diseases who required palliative consultation during hospitalization in an acute regional hospital in northern Israel.\u0000\u0000\u0000BACKGROUND\u0000Prognostication is the ability to evaluate outcome and expected course of a medical condition based on knowledge and experience. Special emphasis is given to the prediction of life expectancy in end-of-life situations, as prognosis directs the treatment approach, the policy regarding tests and procedures, and discharge planning. Research mentions two main methods for assessing life expectancy: one is CPS - Clinician's Prediction of Survival and the other is AES - Actuarial Estimation of Survival based on test results, statistics and clinical tools. Since physical status correlates well with survival, it is included in most prognostication tools.\u0000\u0000\u0000METHODS\u0000A retrospective study for the period January 2015-September 2018 examined the records of patients assessed by the Palliative Consult Team (PCT), using PPS. Variables were initial PPS score, age, gender, ethnic origin, diagnosis and survival time. Patients were monitored six months from initial assessment.\u0000\u0000\u0000RESULTS\u0000A total of 588 patients' records assessed by PCT using PPS, were included in the study. Findings showed PPS to be a significant predictor of survival for all research groups, with no ethnic differences. In the current study population, differences were found between varied diagnoses in life expectancy and functional status. It also became clear that life expectancy of most subjects with a functional status of PPS-40 and below did not exceed six months.\u0000\u0000\u0000DISCUSSION\u0000This research strengthens the link between functional status and life expectancy and is the first in Israel to support the use of the PPS tool as part of the prognostication process in patients with a variety of incurable diseases. The presentation of findings in survival ranges according to the value of PPS is unique to this study and its ability to assist medical staff both in making clinical decisions and in choosing the appropriate terminology for the sensitive and complex procedure of delivering a prognosis to a patient and loved ones.","PeriodicalId":88502,"journal":{"name":"Harefuah. Foreign ed","volume":"328 1","pages":"304-310"},"PeriodicalIF":0.0,"publicationDate":"2019-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77588140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Psoriatic arthritis].","authors":"R. Tur Kaspa, M. Ehrenfeld, M. Eliakim","doi":"10.1891/9780826179357.0332","DOIUrl":"https://doi.org/10.1891/9780826179357.0332","url":null,"abstract":"","PeriodicalId":88502,"journal":{"name":"Harefuah. Foreign ed","volume":"64 1","pages":"668-70"},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76841601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Uterine fibroids].","authors":"Y. Tadir, M. Glezerman, C. Goldchmit","doi":"10.1002/9781119266907.ch12","DOIUrl":"https://doi.org/10.1002/9781119266907.ch12","url":null,"abstract":"Uterine fibroids (leiomyoma) are the most common benign tumors in women. Better understanding of the pathophysiology, as well as recent technical advancements opened the gates for new options for women who suffer from symptomatic uterine fibroids. Treatments are categorized in four groups: surgical removal, minimally invasive or noninvasive approach causing damage to cellular viability, medical treatments to reduce volume and relieve symptoms, and complementary medicine. This review may assist in tailoring the type of treatment according to age, desire for future fertility, size and location of the fibroids.","PeriodicalId":88502,"journal":{"name":"Harefuah. Foreign ed","volume":"110 1","pages":"725-30, 748"},"PeriodicalIF":0.0,"publicationDate":"2018-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80661464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
